Analyst firms · Stifel · RVMD

Stifel RVMD price target and rating history

Revolution Medicines Inc. (RVMD) · Health Care

Stifel rates Revolution Medicines Inc. (RVMD) Buy with a $85 price target, as of its latest action on Oct 16, 2025. It has published 3 rating actions on RVMD since September 2021, including 1 upgrade and 0 downgrades. Across 6 firms with a RVMD price target in the last 12 months, the median target is $165.

Current rating

Buy

Price target

$85

Median target, all firms

$165

Actions on RVMD

3

Stifel price target on RVMD

Every Stifel rating on RVMD

• Oct 16, 2025
  ResumeStifel resumes coverage at Buy, price target $85
• Mar 1, 2022
  UpgradeStifel upgrades to Buy from Hold, price target $36 to $26
• Sep 23, 2021
  InitiateStifel starts coverage at Hold, price target $34

How other firms rate RVMD

Each firm's latest rating and stated target in the last 12 months.

Questions about Stifel and RVMD

What is Stifel's price target for RVMD?

Stifel's latest stated price target for Revolution Medicines Inc. (RVMD) is $85, from its action on Oct 16, 2025.

What is Stifel's rating on RVMD?

Stifel rates RVMD Buy, a bullish rating, as of Oct 16, 2025.

When did Stifel last change its view on RVMD?

On Oct 16, 2025, Stifel resumes coverage at Buy, price target $85.

How does Stifel's RVMD target compare with other analysts?

Across 6 firms with a RVMD price target in the last 12 months, the median target is $165.

More RVMD rating histories

• Goldman Sachs3
• Raymond James3
• Needham3

All Stifel ratingsRVMD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.